In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Robots In The Cath Lab -- Is This The Future Of PCI?

Executive Summary

Robotic-driven technology has begun to transform surgery, but not without leaving some surgeons unimpressed. Now Corindus is trying to bring robots to the cath lab -- and this time physicians love the technology because it provides an ergonomically better experience and both enhances the procedure and reduces health problems.

You may also be interested in...



Robotics: Corindus, Hansen Pursue Vascular Cath Lab Indications

Robot-assisted surgery has generated excitement in recent years, but one high-volume procedure category where robotic equipment has yet to play a significant role is angioplasty and stenting.

Robotics: Corindus, Hansen Pursue Vascular Cath Lab Indications

Robot-assisted surgery has generated excitement in recent years, but one high-volume procedure category where robotic equipment has yet to play a significant role is angioplasty and stenting.

Raising Robotics: An Interview With Intuitive's Lonnie Smith

The tremendous success of Intuitive Surgical over the past two decades seems clearly to argue that robotics is more than a techy's pipedream. Intuitive has already revolutionized at least one procedure - laparoscopic prostatectomy - and it figures to make significant progress in a range of others, in men's health, women's health, and cardiovascular surgery, to name just a few relevant clinical spaces. Even more impressive has been its success as a publicly traded company; for much of the middle years of this decade, Intuitive's stock was the strongest performer among all medical device public offerings. And perhaps most interesting: until recently, Intuitive was virtually the only robotics company to achieve any kind of success at all. In Vivo interviews Lonnie Smith, the CEO of the company for much of the 1990s and 2000s, to whom much of the credit should go.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV003565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel